Dear colleagues,

The following Special Issue will be published in the Antibodies
(http://www.mdpi.com/journal/antibodies/, ISSN 2073-4468) and is now
open to receive submissions of full research papers and comprehensive
review articles for peer-review and possible publication:

Special Issue: Antibody-Drug Conjugates
Website: http://www.mdpi.com/si/antibodies/antibody_drug_conjugates/
Guest Editor: Dr. Nazzareno Dimasi
Deadline for manuscript submissions: 31 October 2012

You may send your manuscript now or up until the deadline.
Submitted papers should not have been published previously, nor be under
consideration for publication elsewhere. We also encourage authors to send
us their tentative title and short abstract by e-mail for approval to the
Editorial Office at antibodies@mdpi.com.

This Special Issue will be fully open access. Open access (unlimited and
free access by readers) increases publicity and promotes more frequent
citations as indicated by several studies. Open access is supported by the
authors and their institutes. More information is available at
http://www.mdpi.com/about/openaccess/.

Article Processing Charges (APC) are waived for well prepared
manuscripts. However, a fee of 250 CHF will apply if extensive
English corrections must be done by the editors. For details see:
http://www.mdpi.com/about/apc/.

Please visit the Instructions for Authors before submitting a manuscript:
http://www.mdpi.com/journal/antibodies/instructions/. Manuscripts should
be submitted through the online manuscript submission and editorial system
at http://www.mdpi.com/user/manuscripts/upload/.

Antibodies (ISSN 2073-4468) is an international, open access journal
which provides an advanced forum for studies related to antibodies and
antigens. The subject areas include antibody-producing cells (including
B cells), antibody structure and function, antibody-antigen interactions,
Fc receptors, antibody manufacturing, antibody engineering, antibody
therapy, immunoassays, antibody diagnosis, tissue antigens, exogenous
antigens, endogenous antigens, autoantigens, monoclonal antibodies, natural
antibodies, humoral immune responses and immunoregulatory molecules.

MDPI publishes several peer-reviewed, open access journals listed at
http://www.mdpi.com/. The Editorial Board members, including several
Nobel Laureates (http://www.mdpi.com/about/nobelists/), are all leading
active scholars. All MDPI journals maintain rapid, yet rigorous, peer-
review, manuscript handling and editorial processes. MDPI journals have
increased their impact factors, see "2010 Newly Released Impact Factors",
http://www.mdpi.com/about/announcements/121/.

In case of questions, please contact the Editorial Office at:
antibodies@mdpi.com.

We are looking forward to hearing from you.

Kind regards,
MDPI AG

On behalf of the Guest Editor

Dr. Nazzareno Dimasi
MedImmune
One MedImmune Way
Gaithersburg, MD 20878
USA
Website: http://www.medimmune.com
E-Mail: dimasin@medimmune.com

--
MDPI AG
Kandererstrasse 25
CH-4057 Basel, Switzerland
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
E-Mail: antibodies@mdpi.com
http://www.mdpi.com/